Stephen Stahl, a psychiatrist and author, discusses 3 reasons to use MAOIs: atypical depression, treatment-resistant depression, and social anxiety disorder. He explores the efficacy and comparison of MAOIs and tricyclic antidepressants, mentions different MAOIs for depression treatment, and highlights the importance of covering unsponsored topics in the psychiatric press.
MAOIs can be beneficial for certain cases of treatment-resistant depression, showing a higher response rate compared to tricyclic antidepressants.
Understanding the specific features of depression, such as atypical or melancholic, is crucial in determining the appropriate usage of MAOIs.
Deep dives
Benefits of MAOIs in Treatment-Resistant Depression
MAOIs are considered a second or third line treatment option for treatment-resistant depression. While the evidence supporting their efficacy is anecdotal, a 1993 study compared phenelzine, an MAOI, with amitriptyline, a tricyclic antidepressant, in patients with chronic non-melancholic treatment-resistant depression. The study showed that switching to phenelzine resulted in a higher response rate (67%) compared to switching to amitriptyline (41%), indicating the potential benefits of MAOIs in certain cases of treatment-resistant depression.
Effectiveness of MAOIs in Atypical Depression
Atypical depression, characterized by symptoms such as increased appetite, oversleeping, and reactive mood, has shown better response to MAOIs. In contrast, melancholic depression, with symptoms like decreased appetite, morning worsening of mood, and non-reactive mood, tends to favor a tricyclic antidepressant approach. Therefore, understanding the specific features of depression, such as atypical or melancholic, is crucial in determining the appropriate usage of MAOIs.
Considerations for MAOI Prescription and Interactions
Prescribing MAOIs requires cautious consideration, especially in terms of drug interactions and the MAOI diet. While the risk of serotonin syndrome is a concern, recent evidence suggests that many tricyclic antidepressants can be used with caution when combined with an MAOI, except for amitriptyline and clomipramine due to their strong serotoninergic reuptake inhibition. Bupropion, mirtazapine, and trazodone are relatively safe to use in combination with MAOIs. It is essential to follow the updated MAOI diet guidelines, which are more liberal and based on modern methods of measuring tyramine content. Overall, selecting the appropriate MAOI depends on factors such as the presence of anxiety or activating properties, patient tolerance, and price considerations.
Stephen Stahl steps down from the industry-sponsored podium to remind us of 3 reasons to use an MAOI: Atypical depression, treatment-resistant depression, and social anxiety disorder.
Chris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode